Happy to share the OUT-POC (One-hoUr Troponin using a high-sensitivity Point-Of-Care assay in emergency primary care) pilot study 🩸🫀
The TriageTrue POC test for hs-cTnI was compared with hs-cTnT at the emergency primary care clinic in Oslo.
https://t.co/We8pyb4Rph
In this collaborative study, we investigated the performance of the prehospital preHEART score, both with and without hs-cTnT, in emergency primary care. 🚨🫀
The study is based on two European cohorts: the TRACE study from the Netherlands, and the OUT-ACS study from Norway.
Adequately identifying low-risk chest pain in emergency primary care: evaluating the performance of preHEAR(T) based on two European cohorts. @tonjerj@dan_atar@drkarthik2010@BoopathyCardio@ubcardio
https://t.co/cbqkj4jWAb
Happy to present our results from the OUT-ACS implementation study, where the 0/1-hour algorithm for hs-cTnT was successfully implemented in emergency primary care 🫀🩺
@dan_atar@sighalvo
https://t.co/d75WlHXJfZ
Back home after another amazing #ESCCongress2024!
Lots of sessions, debates, guideline updates and impressive studies presented ✨👏
Great meeting people and discussing biomarkers and improved chest pain assessment in different settings! ☺️🚑🩺🫀
Grateful for all who participated the evening session yesterday! 😅✨
Presenting the performance on the prehospital preHEART score in the OUT-ACS and TRACE🇳🇱 cohorts!
#ESCCongress2024
Check out our just presented Late-breaking science on a machine learning algorithm using POCT and immediately available clinical variables for immediate rule-out of myocardial infarction:
Happy for the opportunity to present the results from the OUT-ACS implementation study at an exciting session on hs-cTn & integrating evidence from clinical trials and implementation studies🧑⚕️🫀
Great questions and discussions! #ESCCongress2024#troponin
Another great study indicating the clinical utility of high-sensitivity entering the point-of-care troponin test arena. 🚨🚑❤️🩹Congrats to @luca_koechlin, @J_Boeddinghaus, @LopezAyalaP, @mrubini and team!
https://t.co/jVj8ah2HZS
🚨 New data on preloading in suspected NSTE-#ACS — mainly a German issue? Pre-hospital heparin in suspected NSTE-ACS patients may not improve outcomes, raising concerns about widespread use without evidence.🚑 More data urgently needed!
Read more here: https://t.co/qzS7TFY7cq
New article in European Heart Journal @yadersandoval@louiseacullen@mrapple004
Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2 h
https://t.co/LHtWkUvyKY
The #RapidCTCA trial presented by Professor Newby #ICNCCT2024
6 Scottish sites!
No benefit for CTCA in acute intermediate risk chest pain in any subgroups,
likely due in part to the advent of high sensitivity troponin
We are joining forces from Norway and Denmark to investigate this important research question. It big thanks to our study team and participating centers who soon have randomized 5600 pts!
Great webinar on how to recognize an OMI (occlusion MI) at the ECG, and how the queen of hearts AI app may aid our clinical decisions in patients with acute chest pain 🫀👑
🫀 Missed our #BeyondSTEMI#webinar with @smithECGBlog, @PendellM & @RobertHermanMD? Here’s your chance to catch up!
We explored new methods for diagnosing Occlusion Myocardial Infarction (#OMI) with #ECG, moving past the STEMI criteria.
Watch it here: https://t.co/aW95aF2iYp